Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD)
Clinical trial NCT05657691 · COMPLETED
Trial details
- NCT number
- NCT05657691
- Sponsor
- Actinogen Medical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-28
- Primary completion
- 2024-07-01
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.